There were 1,130 press releases posted in the last 24 hours and 405,735 in the last 365 days.

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Achondroplasia, Date of authorisation: 26/08/2021, Revision: 2, Status: Authorised

Voxzogo is given as an injection under the skin once a day, preferably around the same time of day. The site of injection should be changed with each injection. The recommended dose is calculated according to the patient’s body weight. The usual daily dose is 15 microgram per kg body weight.

Treatment should only be started when achondroplasia is confirmed by genetic testing and should end when the patient is not likely to grow any further.

Voxzogo injections can be given by the patients’ caregiver once they have been trained appropriately.

For more information about using Voxzogo, see the package leaflet or contact your doctor or pharmacist.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.